PROGRESS AND PROSPECTS IN CANCER RESEARCH: THERAPEUTIC INNOVATION AND DIAGNOSTIC EVOLUTION

Cancer research has undergone unprecedented acceleration in recent years due to advances in molecular biology, immunology, genomics, and artificial intelligence. The period from 2024 to 2025 has been particularly significant, marked by the approval of novel anticancer agents, progress in personalized immunotherapy, rapid development of antibody–drug conjugates, mRNA-based cancer vaccines, liquid biopsy technologies, and AI-driven diagnostics. These innovations have enhanced tumor specificity, improved survival outcomes, and reduced systemic toxicity. This comprehensive review critically evaluates the most recent advancements in cancer research, emphasizing translational relevance, clinical applicability, and emerging challenges such as drug resistance, tumor heterogeneity, and healthcare accessibility. The review aims to provide pharmacy and biomedical researchers with a detailed overview of contemporary oncology research and its future trajectory.